Medical Director: Precision Medicine

Specialties

• Applied precision medicine
  • Somatic pharmacogenomics
  • Germline pharmacogenomics
• Pharmacoeconomics

Education

• Doctorate Degree—Pharmacy, University of Utah College of Pharmacy
• Fellowship—Personalized Cancer Medicine, Moffitt Cancer Center

Memberships/Affiliations

• American Society of Hematology
• American Society of Health-System Pharmacists
• American Society of Human Genetics
• Clinical Pharmacogenetics Implementation Consortium

Research Interests

• Clinical utility and value of pharmacogenomics
• Gene-drug pair assessment for future implementation
• Patient adherence to pharmacotherapy

Recent Publications

• Nelson RS, Seligson ND, Bottiglieri S, et al. UGT1A1 guided cancer therapy: review of the evidence and considerations for clinical implementation. Cancers (Basel). 2021;13(7):1566.
• Mason NT, Burkett JM, Nelson RS, et al. Budget impact of adaptive abiraterone therapy for castration-resistant prostate cancer. Am Health Drug Benefits. 2021;14(1):15-20.
• Nelson RS, Mehta RJ, McLeod HL, et al. Prioritization of therapy options for a patient with high tumor mutation burden and microsatellite instability but no clinical benefit from immunotherapy. JCO Precis Oncol. 2019;3:PO.19.00197.
• Hunter AM, Nelson R, Hussaini M, et al. CSF3R mutations are exceedingly rare genetic events associated with inferior survival and sensitivity to ruxolitinib across myeloid malignancies. Blood. 2019;134, Supplement 1:4167.
• Stenehjem DD, Au TH, Ngorsuraches S, et al. Immunotargeted therapy in melanoma: patient, provider preferences, and willingness to pay at an academic cancer center.  Melanoma Res. 2019;29(6):626-634.
• Wang Y, Zhang P, Han Y, et al. Adherence to adjuvant imatinib therapy in patients with gastrointestinal stromal tumor in clinical practice: a cross-sectional study. Chemotherapy. 2019;64(4):197-204.
• Zhang M, Zhou H, Nelson RS, et al. Prevalence and risk factors of immunosuppressant nonadherence in heart transplant recipients: a single-center cross-sectional study. Patient Prefer Adherence. 2019;13:2185-2193.

Abstracts/Posters

• J Eli, et al. MetaCensus: a blockchain meta-analysis database to improve scientific consensus and clinical decision support in pharmacogenomics. Abstract 131019, 2022 CPIC-PGRN meeting.
• Nelson RS, et al. Processes for integrating a pharmacogenomics panel into patient care at an academic cancer research hospital. Poster presentation at the Clinical Pharmacogenetics Implementation Consortium (CPIC) open meeting, Memphis TN, June 6-7, 2019.